Literature DB >> 11746979

Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer.

W S Samowitz1, K Curtin, M F Leppert, M L Slattery.   

Abstract

Previous studies have suggested that an allele of the transforming growth factor-beta type I receptor (TGFBRI) gene that codes for six instead of the usual nine alanines in a polyalanine repeat is associated with an increased susceptibility to colon cancer, and that the six-alanine homozygote is seen only in individuals with some form of cancer. We evaluated this TGFBRI polymorphism in a population-based sample of 252 individuals with colon cancer and 362 age- and gender-matched controls from the state of Utah. TGFBRI genotypes were determined by PCR amplification and length determination of the polyalanine repeat. In addition to the common nine-alanine (9A) allele, we identified six- (6A), eight- (8A), ten- (10A), eleven- (11A), and twelve-alanine (12A) TGFBRI alleles. 6A/9A heterozygotes were seen in similar percentages of colon cancer cases (18.3%) and controls (16.0%). 6A/6A homozygotes were slightly more common in controls than in colon cancer cases (1.4% vs. 0.8%), and none of the controls with the 6A/6A genotype had any of the non-colonic cancers reported in previous studies. We conclude that the 6A TGFBRI allele is not associated with an increased susceptibility to colon cancer at the population level, and that the 6A/6A homozygote is not restricted to individuals with some form of cancer. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746979     DOI: 10.1002/gcc.1203

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.

Authors:  Xueli Zhang; Liang Wu; Youhua Sheng; Wenhua Zhou; Zhongming Huang; Jun Qu; Ganglong Gao; Duan Cai; Ming Zhang
Journal:  Mol Biol Rep       Date:  2011-08-20       Impact factor: 2.316

2.  Debate about TGFBR1 and the susceptibility to colorectal cancer.

Authors:  Laura Valle
Journal:  World J Gastrointest Oncol       Date:  2012-01-15

3.  TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.

Authors:  Ru-Yan Liao; Chen Mao; Li-Xin Qiu; Hong Ding; Qing Chen; Hai-Feng Pan
Journal:  Mol Biol Rep       Date:  2009-11-01       Impact factor: 2.316

Review 4.  TGF-beta signaling alterations and susceptibility to colorectal cancer.

Authors:  Yanfei Xu; Boris Pasche
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

Review 5.  TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review.

Authors:  Tony Ibrahim; Charbel Yazbeck; Georges Maalouly; Maria Baz; Fady Haddad; Chadi Sabbagh; Georges Chahine
Journal:  J Gastrointest Cancer       Date:  2014-12

6.  Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain.

Authors:  Jason P Ross; Linda J Lockett; Bruce Tabor; Ian W Saunders; Graeme P Young; Finlay Macrae; Ignacio Blanco; Gabriel Capella; Glenn S Brown; Trevor J Lockett; Garry N Hannan
Journal:  BMC Cancer       Date:  2014-07-01       Impact factor: 4.430

Review 7.  Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.

Authors:  Yong-qiang Wang; Xiao-wei Qi; Fan Wang; Jun Jiang; Qiao-nan Guo
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

8.  Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cells.

Authors:  Kuo-Li Chen; Wan-Hsin Liu; Yi-Yuan Yang; Sy-Jye C Leu; Neng-Yao Shih
Journal:  BMC Mol Biol       Date:  2007-08-17       Impact factor: 2.946

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.